
Steven Rifkind, MS
Advertisement
Articles by Steven Rifkind, MS

Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Real-World Data Show MASH Progresses Faster Than Trials Suggest
2
Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD
3
Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo
4
Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure
5